Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.210
+0.050 (4.31%)
At close: Mar 9, 2026, 4:00 PM EDT
1.200
-0.010 (-0.83%)
After-hours: Mar 9, 2026, 6:30 PM EDT
Phio Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 13 | 11 | 3 | 2 | 5 | 14 | |
| Market Cap Growth | 58.53% | 262.46% | 67.92% | -63.48% | -62.43% | -12.96% | |
| Enterprise Value | -9 | 1 | -2 | -6 | -9 | -13 | |
| Last Close Price | 1.16 | 1.05 | 1.80 | 6.84 | 40.18 | 108.00 | |
| Forward PE | - | - | 0.13 | - | 0.37 | 2.19 | |
| PB Ratio | 0.67 | 0.56 | 0.66 | 0.24 | 0.47 | 0.62 | |
| P/TBV Ratio | 0.61 | 0.56 | 0.66 | 0.24 | 0.47 | 0.62 | |
| Debt / Equity Ratio | - | - | - | 0.01 | 0.02 | 0.01 | |
| Net Debt / Equity Ratio | -1.04 | -1.04 | -1.14 | -1.09 | -1.07 | -1.08 | |
| Net Debt / EBITDA Ratio | 2.28 | 2.28 | 0.73 | 0.79 | 1.02 | 1.77 | |
| Net Debt / FCF Ratio | 2.63 | 2.63 | 0.76 | 0.79 | 0.95 | 2.00 | |
| Quick Ratio | 15.70 | 15.70 | 5.30 | 5.20 | 6.08 | 7.84 | |
| Current Ratio | 16.03 | 16.03 | 5.65 | 5.71 | 6.42 | 8.06 | |
| Return on Equity (ROE) | -69.95% | -69.95% | -114.83% | -116.60% | -70.06% | -76.04% | |
| Return on Assets (ROA) | -42.33% | -42.33% | -61.14% | -60.30% | -37.72% | -41.28% | |
| Return on Capital Employed (ROCE) | -45.80% | -45.80% | -156.40% | -138.40% | -105.40% | -61.10% | |
| Earnings Yield | -70.23% | -76.95% | -229.29% | -582.98% | -225.78% | -98.17% | |
| FCF Yield | -64.52% | -70.70% | -228.10% | -579.10% | -240.93% | -87.99% | |
| Buyback Yield / Dilution | -659.91% | -659.91% | -240.15% | -83.32% | -6.30% | -179.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.